deltatrials
Unknown PHASE1 INTERVENTIONAL 4-arm NCT02975141

Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer (AFFECT)

Gemcitabine and Nab-Paclitaxel Combined With the Oral Irreversible ErbB Family Blocker Afatinib in Patients With Metastatic Pancreatic Cancer: A Phase Ib Trial

Sponsor: PD Dr. med. Volker Heinemann

Conditions Metastatic Pancreatic Cancer
Interventions Abraxane Afatinib 30Mg Tab Afatinib 40Mg Tab Gemzar
Updated 8 times since 2017 Last updated: Aug 9, 2018 Started: Sep 30, 2016 Primary completion: Dec 31, 2018 Completion: Jun 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02975141, this PHASE1 trial focuses on Metastatic Pancreatic Cancer and remains ongoing. Sponsored by PD Dr. med. Volker Heinemann, it has been updated 8 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~Sep 2020 · 24 months · monthly snapshotActive Not Recruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotUnknown Status~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotUnknown Status~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown Status → Unknown

  3. Nov 2022 — Jul 2024 [monthly]

    Unknown Status PHASE1

  4. Jan 2021 — Nov 2022 [monthly]

    Unknown Status PHASE1

  5. Sep 2020 — Jan 2021 [monthly]

    Unknown Status PHASE1

    Status: Active Not Recruiting → Unknown Status

▶ Show 3 earlier versions

  1. Sep 2018 — Sep 2020 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  2. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE1

  3. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

    First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • PD Dr. med. Volker Heinemann
  • Technical University of Munich
  • University of Cologne
Data source: Ludwig-Maximilians - University of Munich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations